Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 4/20 | 0.57 |
| ▸ | NISCH | Q9Y2I1 | 3/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | HTR1B | P28222 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7756299 | 0.98 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBTAAR1 | |
| SCHEMBL1626311 | 0.98 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBTAAR1 | |
| SCHEMBL15561019 | 0.98 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBTAAR1 | |
| SCHEMBL5675527 | 0.98 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBTAAR1 | |
| SCHEMBL107099 | 0.98 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBTAAR1 | |
| SCHEMBL1736375 | 0.98 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBTAAR1 | |
| SCHEMBL2845525 | 0.98 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBTAAR1 | |
| SCHEMBL5680179 | 0.98 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBTAAR1 | |
| Propane SCHEMBL9444503 | 0.98 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBTAAR1 | |
| SCHEMBL10621181 | 0.98 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 692 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117466818-B | Method for preparing 2-aryl imidazoline compounds by solvent-free method | 潍坊弘润新材料有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117466818-A | Method for preparing 2-aryl imidazoline compounds by solvent-free method | 潍坊弘润新材料有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-210946251-U | Antibacterial fabric | 义乌市中力工贸有限公司 | 2020-07-07 | — | — | CN | claimed |
| CN-107419280-A | A kind of stainless steel anti-corrosion passivation cream and preparation method thereof | 苏州吉利不锈钢制品有限公司 | 2017-12-01 | — | — | CN | claimed |
| CN-106536697-A | Fabric and home care treatment compositions | 宝洁公司 | 2017-03-22 | — | — | CN | claimed |
| WO-1999052897-A1 | NOVEL REAGENTS FOR USE AS COUPLING ACTIVATORS AND COUPLING REAGENTS IN ORGANIC SYNTHESIS | NEXSTAR PHARMACEUTICALS, INC. (US) | 1999-10-21 | — | — | WO | claimed |
| EP-0380019-B1 | Methadone fluorescence polarization immunoassay | ABBOTT LAB (US) | 1995-11-08 | — | — | EP | claimed |
| US-12037641-B2 | Modified nucleotide reagents | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| CN-117701325-B | Non-sulfur-chlorine system stainless steel cold rolling oil and preparation method and test method thereof | 超滑科技(佛山)有限责任公司 | 2024-07-16 | — | — | CN | disclosed |
| US-12000000-B2 | Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| CN-113316585-B | 3' -Protected nucleotides | 豪夫迈·罗氏有限公司 | 2024-06-04 | — | — | CN | disclosed |
| US-20240158640-A1 | PROTECTED DYE-LABELED REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2024-05-16 | — | — | US | disclosed |
| CN-117466818-B | Method for preparing 2-aryl imidazoline compounds by solvent-free method | 潍坊弘润新材料有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-4230789-A | SUBSTITUTED IMIDAZOLINE ACID NEUTRALIZERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1980-10-28 | — | — | US | disclosed |
| US-4223087-A | TREATING SURFACE WITH SOLUTION OF A FERRICYANIDE ANION AND A COMPLEXING AGENT; OXIDATION | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1980-09-16 | — | — | US | disclosed |
| US-4219647-A | Certain amides of prostacyclin and related compounds | FRIED JOSEF | 1980-08-26 | — | — | US | disclosed |
| US-4204868-A | PHOTOLITHOGRAPHY OLEOPHILIC SILVER | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1980-05-27 | — | — | US | disclosed |
| US-4082735-A | NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF | SYNTEX (U.S.A.) INC. (US) | 1978-04-04 | — | — | US | disclosed |
| US-4082736-A | NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF | SYNTEX (U.S.A.) INC. (US) | 1978-04-04 | — | — | US | disclosed |
| US-4029702-A | Oil-soluble bicarbamamide compounds | ROHM AND HAAS COMPANY (US) | 1977-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037641-B2 | Modified nucleotide reagents | POLL, POLN, POLM | HTR1D 3377/4885NISCH 612/4885MAOA 2805/4885 |
| US-12000000-B2 | Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing | POLL, POLN, POLB | HTR1D 2944/4885NISCH 769/4885MAOA 2536/4885 |
| US-20240158640-A1 | PROTECTED DYE-LABELED REAGENTS | POLL, POLB, POLM | HTR1D 3296/4885NISCH 913/4885MAOA 2104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.